Evertz Pharma Adds 100 BTC to Treasury Reserves

Evertz Pharma GmbH, a prominent German pharmaceutical company, has made a significant move by adding Bitcoin to its treasury reserves. This strategic decision marks the first instance of a German company adopting a dedicated Bitcoin reserve, reinforcing a Bitcoin strategy that the company initiated in 2020. By allocating 100 BTC to its treasury, Evertz Pharma is not only diversifying its financial holdings but also signaling a strong belief in the long-term value and stability of Bitcoin as a store of value.

The Frankfurt-based firm purchased an additional 100 BTC in May 2025, valued at approximately €10 million (~$10.8 million), expanding its group-wide digital asset reserve. Managing Director Dominik Evertz described Bitcoin as a scarce, globally tradable asset that strengthens long-term financial stability. He said the asset complements the company’s reserves and aligns with its future-focused strategy.

This move is part of a broader shift in the corporate world, where companies are increasingly recognizing the potential of digital assets to enhance their financial resilience and growth prospects. By embracing Bitcoin, Evertz Pharma is positioning itself at the forefront of this trend, demonstrating a forward-thinking approach to financial management.

The decision to add Bitcoin to its treasury reserves is likely driven by several factors. Firstly, Bitcoin's decentralized nature and limited supply make it an attractive option for companies seeking to hedge against inflation and currency devaluation. Secondly, the increasing acceptance of Bitcoin as a legitimate asset class by institutional investors and regulatory bodies provides a level of credibility and security that was previously lacking. Lastly, the potential for significant long-term appreciation in the value of Bitcoin makes it an appealing addition to any company's investment portfolio.

Evertz Pharma's move to adopt a Bitcoin reserve is also a testament to the company's commitment to innovation and technological advancement. By embracing cryptocurrency, Evertz Pharma is not only diversifying its financial holdings but also positioning itself as a leader in the rapidly evolving digital economy. This strategic decision is likely to have a ripple effect, encouraging other companies in the pharmaceutical industry and beyond to explore the potential of Bitcoin and other digital assets.

In conclusion, Evertz Pharma's decision to add Bitcoin to its treasury reserves is a significant development in the corporate world's adoption of cryptocurrencies. This move underscores the growing recognition of Bitcoin's potential as a store of value and a hedge against inflation, as well as the increasing acceptance of digital assets by institutional investors and regulatory bodies. By embracing Bitcoin, Evertz Pharma is positioning itself as a leader in the digital economy, demonstrating a forward-thinking approach to financial management and innovation.